Startseite Current Regulation of Advanced Therapy Medicinal Products in the European Union
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Current Regulation of Advanced Therapy Medicinal Products in the European Union

  • Heide Muckenfuss , Klaus Cichutek und Egbert Flory EMAIL logo
Veröffentlicht/Copyright: 8. Februar 2007
Veröffentlichen auch Sie bei De Gruyter Brill
Journal of international biotechnology law
Aus der Zeitschrift Band 4 Heft 1

Abstract

Background

The rapid biotechnological progress has promoted the development of novel medicinal therapies which are currently changing medical practice substantially. Patients may benefit from new opportunities for the treatment of various diseases, but on the other hand new risks have to be faced. To ensure timely access of patients to innovative medicines while taking safety aspects into consideration, an appropriate legislation is needed. This review aims at giving an overview of the role of the so called “Advanced Therapy Products” in today's medical practice and describes their current regulation in the European Union (EU).

Published Online: 2007-02-08
Published in Print: 2007-01-26

© Walter de Gruyter

Heruntergeladen am 23.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/JIBL.2007.004/html
Button zum nach oben scrollen